RACHAEL GILFUS: Open Payments
NPI 1275226425 · CAMILLUS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$542 in 20 payments from 10 companies in 2025. Trend: 2023 $235 · 2024 $244 · 2025 $542
Food & beverage: $443Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $157 |
| 180 Medical, Inc. | 7 | $141 |
| UROGEN PHARMA, INC. | 2 | $77 |
| Ferring Pharmaceuticals Inc. | 2 | $35 |
| Dendreon Pharmaceuticals LLC | 1 | $27 |
| Telix Pharmaceuticals | 1 | $22 |
| TOLMAR, INC. | 1 | $22 |
| IMMUNITYBIO, INC. | 1 | $21 |
| Medtronic, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
Products named: ERLEADA, GENTLECATH GLIDE, ADSTILADRIN, PROVENGE, ILLUCCIX, JATENZO, ANKTIVA, ALTAVIVA.
Industry payments across NY — which companies pay providers there.
